Seattle, WA (PRWEB) July 18, 2013
Quorum Review IRB, the industry leader in central IRB services, announces its Board Chair, Stephen Rosenfeld, MD, MBA, has been appointed to the Secretary’s Advisory Committee on Human Research Protections (SACHRP). This exclusive panel is selected from the best minds in the research industry to advise the Secretary of Health and Human Services in the area of human research subjects. Kathleen Sibelius is the current Secretary of HHS and has served in that post since her appointment by President Barack Obama in 2009. The Committee was created by previous Secretary Tommy Thompson in 2001.
Dr. Rosenfeld has served in his current role for Quorum Review IRB since January 2012. He brings a wealth of knowledge and expertise to Quorum as well as to his new appointment on the Secretary’s Advisory Committee. Dr. Rosenfeld earned his undergraduate degree in Physics from Yale University in New Haven, CT. He went on to become an MD at Cornell University Medical College in New York. Later, he achieved his MBA status at Georgetown University’s McDonough School of Business in Washington D.C.
Prior to his work with Quorum Review, Dr. Rosenfeld served as the President and CEO of Western IRB in Olympia, WA. He has also held prominent positions with MaineHealth, the Clinical Center at the National Institutes of Health, and the National Heart, Lung, and Blood Institute. He has also been Board-certified in Hematology and Internal Medicine.
Rosenfeld says, "It's a privilege to serve on the Secretary's Advisory Committee as the research enterprise grapples with ethical, regulatory and practical issues that were not envisaged at the time the regulations were written; they include ethical oversight of multi-site trials, genomics and re-identification, and the use of technology and social media in research."
For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.
About Quorum Review IRB
Quorum Review is an independent review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.
Read the full story at http://www.prweb.com/releases/2013/7/prweb10934693.htm.
Copyright©2012 Vocus, Inc.
All rights reserved